Close

Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. SPOT
5. BA
6. META
7. V
8. IBM
9. KMB
10. FI


Go back to Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual
(NASDAQ: LYRA) Delayed: 5.23 +0.02 (0.38%)
Previous Close $5.21    52 Week High $ 
Open $5.25    52 Week Low $ 
Day High $5.42    P/E N/A 
Day Low $5.16    EPS $ 
Volume 120,741